Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii
About Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Akros Pharma Inc.
1
AnaptysBio, Inc.
1
Corbus Pharmaceuticals Inc.
1
Eli Lilly and Company
1
Genentech, Inc.
1
MetrioPharm AG
1
Clinical Trials at Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii
During the past decade, Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis
2019-05-20
2021-04-23
Completed
59
Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis
2018-02-27
2019-06-12
Completed
153
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2018-10-29
2020-03-06
Completed
838
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
2019-02-06
2020-05-05
Completed
65
Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
2018-12-17
2021-10-05
Completed
176
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
2019-01-17
2020-03-13
Completed
152
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
2020-06-15
2024-09-30
Active, not recruiting
1,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" #1 sponsor was "Pfizer" with 2 trials, followed by "Akros Pharma Inc." with 1 trials
sponsored, "AnaptysBio, Inc." with 1 trials sponsored, "Corbus Pharmaceuticals Inc." with 1 trials sponsored and "Eli Lilly and Company"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii"
#1 collaborator was "Bioskin GmbH" with 1 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii
According to Clinical.Site data, the most researched conditions in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" are
"Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials), "Psoriasis" (2 trials), "Skin Diseases" (2 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" in a lesser frequency.
Clinical Trials Intervention Types at Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii
Most popular intervention types in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" are "Drug" (7 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Dupilumab" (1 trials) and "Imsidolimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii
The vast majority of trials in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" are
8 trials for "All" genders.
Clinical Trials Status at Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii
Currently, there are NaN active trials in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".